Product
BAT3306
Aliases
Pembrolizumab Injection
1 clinical trial
2 indications
Indication
cancerIndication
Non-Small Cell LungClinical trial
A Phase I/III, Multi-center, Randomized, Double-blind Study of BAT3306 Plus Chemotherapy Versus Keytruda® Plus Chemotherapy to Evaluate Pharmacokinetics, Efficacy, and Safety in Participants With Stage IV Non-squamous Non-small Cell Lung Cancer.Status: Not yet recruiting, Estimated PCD: 2027-07-30